Misplaced Pages

This is an old revision of this page, as edited by CheMoBot (talk | contribs) at 15:56, 14 September 2011 (Updating {{drugbox}} (no changed fields - added verified revid - updated 'ChemSpiderID_Ref', 'UNII_Ref', 'ChEMBL_Ref', 'ChEBI_Ref', 'KEGG_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref', 'ChEBI_Ref') per Chem/Drugbox validation (report [[Wik). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Nadroparin calcium

Clinical data
AHFS/Drugs.com	International Drug Names
ATC code	B01AB06 (WHO)
Identifiers
CompTox Dashboard (EPA)	DTXSID20872761
ECHA InfoCard	100.029.698
Chemical and physical data
Molar mass	Mean MW = 4500 Daltons
(verify)

Nadroparin is a form of low molecular weight heparin sold by GSK under trademark Fraxiparine.

References

1. GSK PRODUCT MONOGRAPH; http://www.gsk.ca/english/docs-pdf/Fraxiparine_2011.pdf

External links

• http://www.cancer.gov/Templates/drugdictionary.aspx?CdrID=483128
• http://www.mayoclinic.com/health/drug-information/DR600971
• Shafiq N, Malhotra S, Pandhi P, Sharma N, Bhalla A, Grover A (2006). "A randomized controlled clinical trial to evaluate the efficacy, safety, cost-effectiveness and effect on PAI-1 levels of the three low-molecular-weight heparins--enoxaparin, nadroparin and dalteparin. The ESCAPe-END study". Pharmacology. 78 (3): 136–43. doi:10.1159/000096484. PMID 17057417.{{cite journal}}: CS1 maint: multiple names: authors list (link)

This drug article relating to the blood and blood forming organs is a stub. You can help Misplaced Pages by expanding it.

• v
• t
• e

• Blood and blood forming organ drug stubs
• Heparins